Article
Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.
Journal of clinical microbiology - 1 Jul 2012
Park Yongjung, Lee Eunhee, Choi Jonghyeon, Jeong Seri, Kim Hyon-Suk
Abstract excerpt
Infection with high-risk (HR) human papillomavirus (HPV) genotypes is an important risk factor for cervical cancers. We evaluated the clinical performances of two new real-time PCR assays for detecting HR HPVs compared to that of the Hybrid Capture 2 test (HC2). A total of 356 cervical swab specimens, which had been examined for cervical cytology, were assayed by Abbott RealTime HR and Roche Cobas HPV as well as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
